Two Seas Capital LP - Jun 30, 2025 SCHEDULE 13G/A Report for Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share (ADAP)

Filing Manager: Two Seas Capital LP
Reporting Manager: Two Seas Capital LP
Security: Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share
Symbol: ADAP
Shares outstanding: 1.59B shares
Disclosed Ownership: 135M shares
Ownership: 8.5%
Form type: SCHEDULE 13G/A
Date filed: 8/13/2025, 05:43 PM
Date of event: Jun 30, 2025
Previous filing: May 15, 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Two Seas Capital LP	8.5%	135M	135M	/s/ Sina Toussi	Sina Toussi / Managing Member of Two Seas Capital GP LLC, its General Partner
Two Seas Capital GP LLC	8.5%	135M	135M	/s/ Sina Toussi	Sina Toussi / Managing Member
Sina Toussi	8.5%	135M	135M	/s/ Sina Toussi	Sina Toussi / Self